Jiří Mayer

The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution

M. González-Díaz, N. Puig, N. Thielen, 2015, Leukemia.

The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib

S. Mustjoki, H. Klamová, F. Mahon, 2023, Leukemia.

Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF

P. Jindra, A. Folta, T. Papajík, 2024, Leukemia.

Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs

Š. Pospíšilová, A. Hampl, J. Jaros, 2024, Leukemia.